Factors affecting attitudes toward colorectal cancer screening in the primary care population. per Taskila, T, Wilson, S, Damery, S, Roalfe, A, Redman, V, Ismail, T, Hobbs, R

Cost-effectiveness of Helicobacter pylori point of care testing and endoscopy if positive for initial management of dyspepsia in patients under 50 years of age: Results of a primar... per Delaney, B, Wilson, S, Roalfe, A, Roberts, L, Redman, V, Hobbs, R

A randomised controlled trial of early endoscopy for dyspepsia in primary care: Preliminary findings. per Delaney, B, Wilson, S, Roalfe, A, Redman, V, Roberts, L, Hobbs, R

When is prompt endoscopy for dyspepsia cost saving? An extrapolation based on a randomised controlled trial. per Delaney, B, Roalfe, A, Wilson, S, Roberts, L, Redman, V, Hobbs, R

Cost-effectiveness of early endoscopy for dyspepsia in patients of 50 years of age and over: Results of a primary care based randomised controlled trial. per Delaney, B, Wilson, S, Roalfe, A, Roberts, L, Redman, V, Hobbs, R

Cost-effectiveness of early endoscopy for dyspepsia in patients of 50 years of age and over: Results of a primary care-based randomised controlled trial. per Delaney, B, Wilson, S, Roalfe, A, Roberts, L, Redman, V, Hobbs, R

Cost-effectiveness of Helicobacter pylori near patient testing and endoscopy for initial management of dyspepsia in patients under 50 years of age: Results of a primary care-based... per Delaney, B, Wilson, S, Roalfe, A, Roberts, L, Redman, V, Hobbs, R

When is initial endoscopy for dyspepsia in patients of 50 years of age and over cost-neutral? Extrapolation based on results of a primary care-based RCT per Delaney, B, Wilson, S, Roalfe, A, Roberts, L, Redman, V, Hobbs, R

Randomised controlled trials in primary care: case study. per Wilson, S, Delaney, B, Roalfe, A, Roberts, L, Redman, V, Wearn, A, Hobbs, F

Randomised controlled trial of Helicobacter pylori testing and endoscopy for dyspepsia in primary care. per Delaney, B, Wilson, S, Roalfe, A, Roberts, L, Redman, V, Wearn, A, Hobbs, F

Cost effectiveness of initial endoscopy for dyspepsia in patients over age 50 years: a randomised controlled trial in primary care. per Delaney, B, Wilson, S, Roalfe, A, Roberts, L, Redman, V, Wearn, A, Briggs, A, Hobbs, F

Establishing the added benefit of measuring MMP9 in FOB positive patients as a part of the Wolverhampton colorectal cancer screening programme per Wilson, S, Taskila, T, Ismail, T, Stocken, D, Martin, A, Redman, V, Wakelam, M, Perry, I, Hobbs, R

Serum matrix metalloproteinase 9 and colorectal neoplasia: a community-based evaluation of a potential diagnostic test. per Wilson, S, Damery, S, Stocken, D, Dowswell, G, Holder, R, Ward, S, Redman, V, Wakelam, M, James, J, Hobbs, F, Ismail, T

Serum matrix metalloproteinase 9 and colorectal neoplasia: A community-based evaluation of a potential diagnostic test per Wilson, S, Damery, S, Stocken, D, Dowswell, G, Holder, R, Ward, S, Redman, V, Wakelam, M, James, J, Hobbs, R, Ismail, T

Evaluation of the accuracy of serum MMP-9 as a test for colorectal cancer in a primary care population. per Wilson, S, Wakelam, M, Hobbs, R, Ryan, A, Dunn, J, Redman, V, Patrick, F, Colbourne, L, Martin, A, Ismail, T

Evaluation of the accuracy of serum MMP-9 as a test for colorectal cancer in a primary care population per Wilson, S, Wakelam, M, Hobbs, R, Ryan, A, Dunn, J, Redman, V, Patrick, F, Colbourne, L, Martin, A, Ismail, T

Cluster randomised controlled trial comparing the effectiveness and cost-effectiveness of two primary care interventions aimed at improving attendance for breast screening. per Richards, S, Bankhead, C, Peters, T, Austoker, J, Hobbs, F, Brown, J, Tydeman, C, Roberts, L, Formby, J, Redman, V, Wilson, S, Sharp, D

Improving attendance for breast screening among recent non-attenders: a randomised controlled trial of two interventions in primary care. per Bankhead, C, Richards, S, Peters, T, Sharp, D, Hobbs, F, Brown, J, Roberts, L, Tydeman, C, Redman, V, Formby, J, Wilson, S, Austoker, J

Spironolactone to prevent cardiovascular events in early-stage chronic kidney disease (STOP-CKD): Study protocol for a randomized controlled pilot trial per Ng, K, Jain, P, Heer, G, Redman, V, Chagoury, O, Dowswell, G, Greenfield, S, Freemantle, N, Townend, J, Gill, P, McManus, R, Ferro, C

Spironolactone to prevent cardiovascular events in early-stage chronic kidney disease (STOP-CKD): study protocol for a randomized controlled pilot trial. per Ng, K, Jain, P, Heer, G, Redman, V, Chagoury, O, Dowswell, G, Greenfield, S, Freemantle, N, Townend, J, Gill, P, McManus, R, Ferro, C